Stay updated on Cabozantinib in Advanced Soft Tissue Sarcoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Advanced Soft Tissue Sarcoma Clinical Trial page.

Latest updates to the Cabozantinib in Advanced Soft Tissue Sarcoma Clinical Trial page
- Check3 days agoChange DetectedMinor formatting and wording updates observed in the Study Details sections; no changes to eligibility criteria, primary outcomes, or study status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check11 days agoNo Change Detected
- Check32 days agoChange DetectedAdded a government-operating-status notice and a version bump to v3.2.0; removed the previous version label v3.1.0.SummaryDifference2%

- Check39 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.0%

- Check54 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; 'Back to Top' was removed. No other substantial changes to core content, pricing, stock, or time-related details.SummaryDifference0.1%

- Check61 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%

- Check68 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, as well as the introduction of cabozantinib related to soft tissue sarcoma. The revision number has also been updated from v2.16.12 to v3.0.0.SummaryDifference0.5%

Stay in the know with updates to Cabozantinib in Advanced Soft Tissue Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Advanced Soft Tissue Sarcoma Clinical Trial page.